Endeavour creates new intermediates for prion drug developers

from Outsourcing-Pharma Podcast · host William Reed Ltd

Endeavour Specialty Chemicals has launched a novel range of pyridinyl thioureas designed to cater for growing pharmaceutical industry interest in the development of prion disease treatments.

Episode metadata supplied by the publisher feed · Published Nov 16, 2011

Embed this episode

Attribution link and audio player

NOW PLAYING

Endeavour creates new intermediates for prion drug developers

0:00 3:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Outsourcing-Pharma Podcast?

This episode is 3 minutes long.

When was this Outsourcing-Pharma Podcast episode published?

This episode was published on November 16, 2011.

Can I download this Outsourcing-Pharma Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!